NovaBridge Biosciences (NBP) Receivables - Net (2019 - 2023)

NovaBridge Biosciences (NBP) has 5 years of Receivables - Net data on file, last reported at $743603.1 in Q4 2023.

• Quarterly Receivables - Net fell 79.24% year-over-year to $743603.1 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $743603.1 (down 79.24% YoY) and the FY2023 annual result came in at $743603.1, up 126.99% from the prior year.
• Receivables - Net declined to $743603.1 in Q4 2023 per NBP's latest filing, from $3.6 million in the prior quarter.
• Across five years, Receivables - Net topped out at $20.2 million in Q2 2021 and bottomed at $76000.0 in Q2 2022.
• The 5-year median for Receivables - Net is $1.4 million (2021), against an average of $4.0 million.
• The widest annual swing landed in 2020, when Receivables - Net jumped 215.61%; it then plunged 99.62% in 2022.
• Tracing NBP's Receivables - Net over 5 years: stood at $556172.6 in 2019, then jumped by 215.61% to $1.8 million in 2020, then decreased by 17.88% to $1.4 million in 2021, then surged by 148.44% to $3.6 million in 2022, then plunged by 79.24% to $743603.1 in 2023.
• Per Business Quant, the three latest NBP Receivables - Net figures stand at $743603.1 (Q4 2023), $3.6 million (Q4 2022), and $76000.0 (Q2 2022).

Peer Comparison